Early short-term antiretroviral therapy is associated with a reduced prevalence of CD8+FoxP3+ T cells in simian immunodeficiency virus-infected controller rhesus macaques

AIDS Research and Human Retroviruses

Volumn 27, Issue 7, 2011, Pages 763-775

  George, Jeffy ^a   Cofano, Egidio Brocca ^b   Lybarger, Elizabeth ^c   Louder, Mark ^c   Lafont, Bernard A P ^c   Mascola, John R ^c   Robert Guroff, Marjorie ^b   Mattapallil, Joseph J ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EMTRICITABINE; GAG PROTEIN; GAMMA INTERFERON; INTERLEUKIN 2; KI 67 ANTIGEN; POL PROTEIN; TENOFOVIR; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; HOMEOSTASIS; HUMAN; HUMAN CELL; LENTIVIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RHESUS MONKEY; SHORT COURSE THERAPY; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS INFECTION; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME; VIRUS LOAD; VIRUS NEUTRALIZATION;

ANIMALS; ANTI-HIV AGENTS; ANTIGENS, CD8; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FORKHEAD TRANSCRIPTION FACTORS; IMMUNE TOLERANCE; MACACA MULATTA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; T-LYMPHOCYTES, REGULATORY;

EID: 79959847581     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2010.0251     Document Type: Article

References (72)

1. Mills KH: Regulatory T cells: Friend or foe in immunity to infection? Nat Rev Immunol 2004;4(11):841-855. (Pubitemid 39490760)
2. Morgan ME, van Bilsen JH, Bakker AM, et al.: Expression of FOXP3 mRNA is not confined to CD4\+CD25\+ T regulatory cells in humans. Hum Immunol 2005;66(1):13-20. (Pubitemid 40037706)
3. Bacchetta R, Passerini L, Gambineri E, et al.: Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest 2006;116(6):1713-1722.
4. Elrefaei M, Ventura FL, Baker CA, Clark R, Bangsberg DR, and Cao H: HIV-specific IL-10-positive CD8\+ T cells suppress cytolysis and IL-2 production by CD8\+ T cells. J Immunol 2007;178(5):3265-3271. (Pubitemid 46333210)
5. Andersson J, Boasso A, Nilsson J, et al.: The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol 2005;174(6): 3143-3147. (Pubitemid 40354012)
6. Boasso A, Vaccari M, Hryniewicz A, et al.: Regulatory T-cell markers, indoleamine 2,3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection. J Virol 2007;81(21):11593-11603. (Pubitemid 47623791)
7. Cecchinato V, Tryniszewska E, Ma ZM, et al.: Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. J Immunol 2008;180(8):5439-5447.
8. Dunham RM, Cervasi B, Brenchley JM, et al.: CD127 and CD25 expression defines CD4\+ T cell subsets that are differentially depleted during HIV infection. J Immunol 2008; 180(8):5582-5592.
9. Hartigan-O'Connor DJ, Abel K, and McCune JM: Suppression of SIV-specific CD4\+ T cells by infant but not adult macaque regulatory T cells: Implications for SIV disease progression. J Exp Med 2007;204(11):2679-2692. (Pubitemid 350044791)
10. Kinter AL, Hennessey M, Bell A, et al.: CD25(\+)CD4(\+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(\+) and CD8(\+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 2004;200(3):331-343. (Pubitemid 39031252)
11. Macatangay BJ, Szajnik ME, Whiteside TL, Riddler SA, and Rinaldo CR: Regulatory T cell suppression of Gag-specific CD8 T cell polyfunctional response after therapeutic vaccination of HIV-1-infected patients on ART. PLoS One 2010;5(3):e9852.
12. Nigam P, Velu V, Kannanganat S, et al.: Expansion of FOXP3\+ CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic simian immunodeficiency virus infection correlates with diminished antiviral T cell response and viral control. J Immunol. 2010;184(4):1690-1701.
13. Nilsson J, Boasso A, Velilla PA, et al.: HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 2006;108(12): 3808-3817. (Pubitemid 44864563)
14. Oswald-Richter K, Grill SM, Shariat N, et al.: HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol 2004;2(7):E198.
15. Aandahl EM, Michaelsson J, Moretto WJ, Hecht FM, and Nixon DF: Human CD4\+ CD25\+ regulatory T cells control T-cell responses to human immunodeficiency virus and cy-tomegalovirus antigens. J Virol 2004;78(5):2454-2459. (Pubitemid 38228938)
16. Chase AJ, Sedaghat AR, German JR, et al.: Severe depletion of CD4\+ CD25\+ regulatory T cells from the intestinal lamina propria but not peripheral blood or lymph nodes during acute simian immunodeficiency virus infection. J Virol 2007; 81(23):12748-12757. (Pubitemid 350156912)
17. Chase AJ, Yang HC, Zhang H, Blankson JN, and Siliciano RF: Preservation of FoxP3\+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4\+ T-cell activation. J Virol 2008;82(17):8307-8315.
18. Pereira LE, Villinger F, Onlamoon N, et al.: Simian immunodeficiency virus (SIV) infection influences the level and function of regulatory T cells in SIV-infected rhesus macaques but not SIV-infected sooty mangabeys. J Virol 2007;81(9):4445-4456. (Pubitemid 46668642)
19. Cao W, Jamieson BD, Hultin LE, Hultin PM, and Detels R: Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression. AIDS Res Hum Retroviruses 2009;25(2): 183-191.
20. Karlsson I, Malleret B, Brochard P, et al.: FoxP3\+ CD25\+ CD8\+ T-cell induction during primary simian immunodeficiency virus infection in cynomolgus macaques correlates with low CD4\+ T-cell activation and high viral load. J Virol 2007;81(24):13444-13455. (Pubitemid 350247840)
21. Lim A, French MA, and Price P: CD4\+ and CD8\+ T cells expressing FoxP3 in HIV-infected patients are phenotypi-cally distinct and influenced by disease severity and anti-retroviral therapy. J Acquir Immune Defic Syndr 2009; 51(3):248-257.
22. Kader M, Hassan WM, Eberly M, et al.: Antiretroviral therapy prior to acute viral replication preserves CD4 T cells in the periphery but not in rectal mucosa during acute simian immunodeficiency virus infection. J Virol 2008;82(22): 11467-11471.
23. Kubo M, Nishimura Y, Shingai M, et al.: Initiation of an-tiretroviral therapy 48 hours after infection with simian immunodeficiency virus potently suppresses acute-phase viremia and blocks the massive loss of memory CD4\+ T cells but fails to prevent disease. J Virol 2009;83(14): 7099-7108.
24. Lifson JD, Piatak M, Jr., Cline AN, et al.: Transient early post-inoculation anti-retroviral treatment facilitates controlled infection with sparing of CD4\+ T cells in gut-associated lymphoid tissues in SIVmac239-infected rhesus macaques, but not resistance to rechallenge. J Med Primatol 2003; 32(4-5):201-210. (Pubitemid 37021245)
25. Verhoeven D, Sankaran S, Silvey M, and Dandekar S: Antiviral therapy during primary SIV infection fails to prevent acute CD4\+ T-cell loss in gut mucosa but enhances their rapid restoration through central memory T-cells. J Virol 2008;82(8):4016-4027. (Pubitemid 351521237)
26. Baker CA, Clark R, Ventura F, et al.: Peripheral CD4 loss of regulatory T cells is associated with persistent viraemia in chronic HIV infection. Clin Exp Immunol 2007;147(3): 533-539. (Pubitemid 46208056)
27. Gaardbo JC, Nielsen SD, Vedel SJ, et al.: Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy. Clin Exp Immunol 2008;154(1):80-86.
28. Kolte L, Gaardbo JC, Skogstrand K, Ryder LP, Ersboll AK, and Nielsen SD: Increased levels of regulatory T cells (Tregs) in human immunodeficiency virus-infected patients after 5 years of highly active anti-retroviral therapy may be due to increased thymic production of naive Tregs. Clin Exp Immunol 2009;155(1):44-52.
29. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, and Roederer M: Massive infection and loss of memory CD4\+ T cells in multiple tissues during acute SIV infection. Nature 2005;434(7037):1093-1097. (Pubitemid 40663481)
30. Endo Y, Igarashi T, Nishimura Y, et al.: Short-and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus. J Virol 2000;74(15):6935-6945. (Pubitemid 30470676)
31. Perfetto SP, Chattopadhyay PK, Lamoreaux L, et al.: Amine reactive dyes: An effective tool to discriminate live and dead cells in polychromatic flow cytometry. J Immunol Methods 2006;313(1-2):199-208.
32. Pitcher CJ, Hagen SI, Walker JM, et al.: Development and homeostasis of T cell memory in rhesus macaque. J Immunol 2002;168(1):29-43. (Pubitemid 34014099)
33. Lafont BA, McGraw CM, Stukes SA, et al.: The locus encoding an oligomorphic family of MHC-A alleles (Mane-A*06/Mamu-A*05) is present at high frequency in several macaque species. Immunogenetics 2007;59(3):211-223. (Pubitemid 46215294)
34. Loffredo JT, Maxwell J, Qi Y, et al.: Mamu-B*08-positive macaques control simian immunodeficiency virus replication. J Virol 2007;81(16):8827- 8832. (Pubitemid 47242856)
35. Ourmanov I, Kuwata T, Goeken R, et al.: Improved survival in rhesus macaques immunized with modified vaccinia virus Ankara recombinants expressing simian immunodeficiency virus envelope correlates with reduction in memory CD4\+ T-cell loss and higher titers of neutralizing antibody. J Virol 2009;83(11):5388-5400.
36. Kaizu M, Borchardt GJ, Glidden CE, et al.: Molecular typing of major histocompatibility complex class I alleles in the Indian rhesus macaque which restrict SIV CD8\+ T cell epi-topes. Immunogenetics 2007;59(9):693-703. (Pubitemid 47415561)
37. Florese RH, Demberg T, Xiao P, et al.: Contribution of non-neutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines. J Immunol 2009;182(6):3718-3727.
38. Florese RH, Van Rompay KK, Aldrich K, et al.: Evaluation of passively transferred, nonneutralizing antibody-dependent cellular cytotoxicity-mediating IgG in protection of neonatal rhesus macaques against oral SIVmac251 challenge. J Immunol 2006;177(6):4028-4036. (Pubitemid 44359936)
39. Gomez-Roman VR, Florese RH, Patterson LJ, et al.: A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity. J Immunol Methods 2006;308(1-2):53-67. (Pubitemid 43107954)
40. Gomez-Roman VR, Florese RH, Peng B, et al.: An adenovi-rus-based HIV subtype B prime/boost vaccine regimen elicits antibodies mediating broad antibody-dependent cellular cytotoxicity against non-subtype B HIV strains. J Acquir Immune Defic Syndr 2006;43(3):270-277. (Pubitemid 44674006)
41. Hidajat R, Xiao P, Zhou Q, et al.: Correlation of vaccine-elicited systemic and mucosal nonneutralizing antibody activities with reduced acute viremia following intrarectal simian immunodeficiency virus SIVmac251 challenge of rhesus macaques. J Virol 2009;83(2):791-801.
42. Xiao P, Zhao J, Patterson LJ, et al.: Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques. J Virol 2010; 84(14):7161-7173.
43. Wu X, Zhou T, O'Dell S, Wyatt RT, Kwong PD, and Mascola JR: Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody B12 that effectively targets the site of CD4 attachment. J Virol 2009;83(21):10892-10907.
44. Li M, Gao F, Mascola JR, et al.: Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J Virol 2005;79(16):10108-10125. (Pubitemid 41098552)
45. Shu Y, Winfrey S, Yang ZY, et al.: Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs. Vaccine 2007;25(8):1398-1408. (Pubitemid 46074300)
46. Douek DC, Picker LJ, and Koup RA: T cell dynamics in HIV-1 infection. Annu Rev Immunol 2003;21:265-304. (Pubitemid 37174533)
47. Malhotra U, Holte S, Dutta S, et al.: Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment. J Clin Invest 2001;107(4): 505-517. (Pubitemid 32167997)
48. Oxenius A, Price DA, Easterbrook PJ, et al.: Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8\+ and CD4\+ T lymphocytes. Proc Natl Acad Sci USA 2000;97(7):3382-3387. (Pubitemid 30183311)
49. Rosenberg ES, Altfeld M, Poon SH, et al.: Immune control of HIV-1 after early treatment of acute infection. Nature 2000; 407(6803):523-526.
50. Rosenberg ES, Billingsley JM, Caliendo AM, et al.: Vigorous HIV-1-specific CD4\+ T cell responses associated with control of viremia. Science 1997;278(5342):1447-1450. (Pubitemid 27509814)
51. Brenchley JM, Schacker TW, Ruff LE, et al.: CD4\+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004;200(6): 749-759. (Pubitemid 39299461)
52. Eberly MD, Kader M, Hassan W, et al.: Increased IL-15 production is associated with higher susceptibility of memory CD4 T cells to simian immunodeficiency virus during acute infection. J Immunol 2009;182(3):1439-1448.
53. Guadalupe M, Reay E, Sankaran S, et al.: Severe CD4\+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 2003;77(21):11708-11717. (Pubitemid 37271669)
54. Kader M, Wang X, Piatak M, Jr., et al.: a4\+b7hi CD4\+ memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection. Mucosal Immunol 2009;doi:10.1038/mi.2009.90.
55. Li Q, Duan L, Estes JD, et al.: Peak SIV replication in resting memory CD4\+ T cells depletes gut lamina propria CD4\+ T cells. Nature 2005;434(7037):1148-1152. (Pubitemid 40663495)
56. Mehandru S, Poles MA, Tenner-Racz K, et al.: Primary HIV-1 infection is associated with preferential depletion of CD4\+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004;200(6):761-770. (Pubitemid 39299462)
57. Veazey RS, DeMaria M, Chalifoux LV, et al.: Gastrointestinal tract as a major site of CD4\+ T cell depletion and viral replication in SIV infection. Science 1998;280(5362):427-431. (Pubitemid 28208163)
58. Kinter A, McNally J, Riggin L, Jackson R, Roby G, and Fauci AS: Suppression of HIV-specific T cell activity by lymph node CD25\+ regulatory T cells from HIV-infected individuals. Proc Natl Acad Sci USA 2007;104(9):3390- 3395. (Pubitemid 46364169)
59. Kinter AL, Horak R, Sion M, et al.: CD25\+ regulatory T cells isolated from HIV-infected individuals suppress the cyto-lytic and nonlytic antiviral activity of HIV-specific CD8\+ T cells in vitro. AIDS Res Hum Retroviruses 2007;23(3): 438-450. (Pubitemid 46608564)
60. Tang Q and Bluestone JA: The Foxp3\+ regulatory T cell: A jack of all trades, master of regulation. Nat Immunol 2008; 9(3):239-244. (Pubitemid 351267321)
61. Lichterfeld M, Kaufmann DE, Yu XG, et al.: Loss of HIV-1-specific CD8\+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4\+ T cells. J Exp Med 2004;200(6):701-712. (Pubitemid 39299457)
62. Cantor H, Shen FW, and Boyse EA: Separation of helper T cells from suppressor T cells expressing different Ly components. II. Activation by antigen: After immunization, antigen-specific suppressor and helper activities are mediated by distinct T-cell subclasses. J Exp Med 1976;143(6): 1391-1340.
63. Noble A, Zhao ZS, and Cantor H: Suppression of immune responses by CD8 cells. II. Qa-1 on activated B cells stimulates CD8 cell suppression of T helper 2 responses. J Immunol 1998;160(2):566-571. (Pubitemid 28049294)
64. Koh DR, Fung-Leung WP, Ho A, Gray D, Acha-Orbea H, and Mak TW: Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/-mice. Science 1992;256(5060):1210-1213.
65. Penninger JM, Neu N, Timms E, et al.: The induction of experimental autoimmune myocarditis in mice lacking CD4 or CD8 molecules [corrected]. J Exp Med 1993;178(5): 1837-1842. (Pubitemid 23318467)
66. Garba ML, Pilcher CD, Bingham AL, Eron J, and Frelinger JA: HIV antigens can induce TGF-beta(1)-producing immu-noregulatory CD8\+ T cells. J Immunol 2002;168(5):2247-2254. (Pubitemid 34173033)
67. Estes JD, Li Q, Reynolds MR, et al.: Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J Infect Dis 2006;193(5):703-712. (Pubitemid 43271504)
68. Estes JD, Wietgrefe S, Schacker T, et al.: Simian immunodeficiency virus-induced lymphatic tissue fibrosis is mediated by transforming growth factor beta 1-positive regulatory T cells and begins in early infection. J Infect Dis 2007; 195(4):551-561. (Pubitemid 46214398)
69. Epple HJ, Loddenkemper C, Kunkel D, et al.: Mucosal but not peripheral FOXP3\+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 2006;108(9):3072-3078.
70. Favre D, Lederer S, Kanwar B, et al.: Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog 2009;5(2):e1000295.
71. Moreno-Fernandez ME, Zapata W, Blackard JT, Franchini G, and Chougnet CA: Human regulatory T cells are targets for human immunodeficiency virus (HIV) infection, and their susceptibility differs depending on the HIV type 1 strain. J Virol 2009;83(24):12925-12933.
72. Allers K, Loddenkemper C, Hofmann J, et al.: Gut mucosal FOXP3\+ regulatory CD4\+ T cells and nonregulatory CD4\+ T cells are differentially affected by simian immunodeficiency virus infection in rhesus macaques. J Virol 2010; 84(7):3259-3269.